N. ELALDI, "Immunotherapy in CCHF: why, when and which patient?," CCHF diagnostic and treatment by using human monoclonal antibodies , STOOCKHOLM, Sweden, 2017
ELALDI, N. 2017. Immunotherapy in CCHF: why, when and which patient?. CCHF diagnostic and treatment by using human monoclonal antibodies , (STOOCKHOLM, Sweden).
ELALDI, N., (2017). Immunotherapy in CCHF: why, when and which patient? . CCHF diagnostic and treatment by using human monoclonal antibodies, STOOCKHOLM, Sweden
ELALDI, NAZİF. "Immunotherapy in CCHF: why, when and which patient?," CCHF diagnostic and treatment by using human monoclonal antibodies, STOOCKHOLM, Sweden, 2017
ELALDI, NAZİF. "Immunotherapy in CCHF: why, when and which patient?." CCHF diagnostic and treatment by using human monoclonal antibodies , STOOCKHOLM, Sweden, 2017
ELALDI, N. (2017) . "Immunotherapy in CCHF: why, when and which patient?." CCHF diagnostic and treatment by using human monoclonal antibodies , STOOCKHOLM, Sweden.
@conferencepaper{conferencepaper, author={NAZİF ELALDI}, title={Immunotherapy in CCHF: why, when and which patient?}, congress name={CCHF diagnostic and treatment by using human monoclonal antibodies}, city={STOOCKHOLM}, country={Sweden}, year={2017}}